Fig. 7
From: Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease
ET-1 plasma concentration in N-P: normoxia (FiO2 0.21)-placebo (n = 6), N-M: normoxia (FiO2 0.21)-macitentan (n = 8); H-P: hyperoxia (FiO2 1.0)-placebo (n = 6); and H-M: hyperoxia (FiO2 1.0)-macitentan (n = 6). Data are expressed as vertical box plots with median, 10th, 25th, 75th, and 90th percentiles. * and # indicate significant difference to FiO2 0.21-placebo, and FiO2 1.0-placebo, respectively, p < 0.05